Kriterien zur Evaluation des Ansprechens auf Biologika bei schwerem Asthma – der Biologics Asthma Response Score (BARS)

Background  The introduction of monoclonal antibodies (biologics) has revolutionized the therapy of severe asthma. Even though there is a response in the majority of patients, the degree of response varies. To date criteria for assessment of response to biologics are not consistently defined. Aim  T...

Descripción completa

Detalles Bibliográficos
Autores principales: Milger, Katrin, Korn, Stephanie, Feder, Claudia, Fuge, Jan, Mühle, Andreas, Schütte, Wolfgang, Skowasch, Dirk, Timmermann, Hartmut, Suhling, Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104728/
https://www.ncbi.nlm.nih.gov/pubmed/36796422
http://dx.doi.org/10.1055/a-2014-4350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104728/
https://www.ncbi.nlm.nih.gov/pubmed/36796422
http://dx.doi.org/10.1055/a-2014-4350

Ejemplares similares